These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 407613)

  • 1. Behavioral effects of apomorphine and diisobutyrylapomorphine in the mouse.
    Baldessarini RJ; Kula NS; Walton KG
    Psychopharmacology (Berl); 1977 Jun; 53(1):45-53. PubMed ID: 407613
    [No Abstract]   [Full Text] [Related]  

  • 2. Prolonged apomorphine-like behavioural effects of apomorphine esters.
    Borgman RJ
    Neuropharmacology; 1976 Aug; 15(8):471-8. PubMed ID: 988501
    [No Abstract]   [Full Text] [Related]  

  • 3. Hydrolysis of diester prodrugs of apomorphine.
    Baldessarini RJ; Kula NS; Walton KG; Borgman RJ
    Biochem Pharmacol; 1977 Oct; 26(19):1749-56. PubMed ID: 907714
    [No Abstract]   [Full Text] [Related]  

  • 4. The dopaminergic and antidopaminergic effects of some aporphines.
    Tolosa ES; Cotzias GC; Burckhardt PG; Tang LC; Dahl KE
    Exp Neurol; 1977 Apr; 55(1):56-66. PubMed ID: 557416
    [No Abstract]   [Full Text] [Related]  

  • 5. Apomorphine-induced rotation in the unilateral 6-OHDA-lesioned rat: relationship to changes in striatal adenylate cyclase activity and 3H-spiperone binding.
    Waddington JL; Cross AJ; Longden A; Owen F; Poulter M
    Neuropharmacology; 1979 Jul; 18(7):643-5. PubMed ID: 573871
    [No Abstract]   [Full Text] [Related]  

  • 6. Potentiation of apomorphine-induced stereotyped behaviour by acute treatment with dopamine depleting agents: a potential role for an increased stimulation of D1 dopamine receptors.
    Vasse M; Protais P
    Neuropharmacology; 1989 Sep; 28(9):931-9. PubMed ID: 2554186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopaminergic denervation supersensitivity and dopamine stimulated adenyl cyclase activity.
    Von Voigtlander PF; Boukma SJ; Johnson GA
    Neuropharmacology; 1973 Nov; 12(11):1081-6. PubMed ID: 4358568
    [No Abstract]   [Full Text] [Related]  

  • 8. The distribution of apomorphine in rat brain: possible behavioral correlates.
    Melzacka M; Wiszniowska G; Vetulani J
    Pol J Pharmacol Pharm; 1978; 30(2-3):335-45. PubMed ID: 566915
    [No Abstract]   [Full Text] [Related]  

  • 9. Esters of apomorphine and N,N-dimethyldopamine as agonists of dopamine receptors in the rat brain in vivo.
    Baldessarini RJ; Walton KG; Borgman RJ
    Neuropharmacology; 1975 Oct; 14(10):725-31. PubMed ID: 1238952
    [No Abstract]   [Full Text] [Related]  

  • 10. Multiple receptors for brain dopamine in behavior regulation: concept of dopamine-E and dopamine-I receptors.
    Cools AR; van Rossum JM
    Life Sci; 1980 Oct; 27(14):1237-53. PubMed ID: 6255271
    [No Abstract]   [Full Text] [Related]  

  • 11. Dopamine receptor sensitivity after repeated morphine administrations to rats.
    Kuschinsky K
    Life Sci; 1975 Jul; 17(1):43-8. PubMed ID: 167254
    [No Abstract]   [Full Text] [Related]  

  • 12. Tolerance to stereotyped behaviour and to decrease in striatal homovanillic acid levels after repeated treatment with apomorphine dipivaloyl ester.
    Worms P; Scatton B
    Eur J Pharmacol; 1977 Oct; 45(4):395-6. PubMed ID: 562764
    [No Abstract]   [Full Text] [Related]  

  • 13. The effects of cholinergic agonists on apomorphine-induced stereotyped behavior in the rat.
    Sahakian BJ; Growdon JH; Millington WR; Barr JK; Wurtman RJ
    Commun Psychopharmacol; 1978; 2(3):255-62. PubMed ID: 568059
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of dopamine-like drugs on rat striatal adenyl cyclase have implications for CNS dopamine receptor topography.
    Miller R; Horn A; Iversen L; Pinder R
    Nature; 1974 Jul; 250(463):238-41. PubMed ID: 4368645
    [No Abstract]   [Full Text] [Related]  

  • 15. Differentiation of the dopamine mechanisms mediating stereotyped behaviour and hyperactivity in the nucleus accumbens and caudate-putamen.
    Costall B; Naylor RJ; Cannon JG; Lee T
    J Pharm Pharmacol; 1977 Jun; 29(6):337-42. PubMed ID: 18569
    [No Abstract]   [Full Text] [Related]  

  • 16. Supersensitivity to d-amphetamine- and apomorphine-induced stereotyped behavior induced by chronic d-amphetamine administration.
    Klawans HL; Margolin DI; Dana N; Crosset P
    J Neurol Sci; 1975 Jul; 25(3):283-9. PubMed ID: 1171935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacology and physiology of stereotyped behavior.
    Randrup A; Munkvad I
    J Psychiatr Res; 1974; 11():1-10. PubMed ID: 4218871
    [No Abstract]   [Full Text] [Related]  

  • 18. Climbing behavior induced by apomorphine in mice: a simple test for the study of dopamine receptors in striatum.
    Protais P; Costentin J; Schwartz JC
    Psychopharmacology (Berl); 1976 Oct; 50(1):1-6. PubMed ID: 827755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological basis for N-n-propylnorapomorphine induced stereotypic cage climbing and behavioral arousal in mice.
    Wilcox RE; Riffee WH; Smith RV
    Pharmacol Biochem Behav; 1979 Dec; 11(6):653-9. PubMed ID: 43980
    [No Abstract]   [Full Text] [Related]  

  • 20. Aporphines. 39. Synthesis, dopamine receptor binding, and pharmacological activity of (R)-(-)- and (S)-(+)-2-hydroxyapomorphine.
    Neumeyer JL; Arana GW; Ram VJ; Kula NS; Baldessarini RJ
    J Med Chem; 1982 Aug; 25(8):990-2. PubMed ID: 7120288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.